您的位置: 首页 > 农业专利 > 详情页

ANTICORPS BISPECIFIQUES ANTI-MUC16-CD3 ET CONJUGUES MEDICAMENT ANTI-MUC16
专利权人:
INC.;REGENERON PHARMACEUTICALS
发明人:
HABER, LAURIC,SMITH, ERIC,KELLY, MARCUS,KIRSHNER, JESSICA R.,COETZEE, SANDRA,CRAWFORD, ALISON,NITTOLI, THOMAS,LIU, YASHU
申请号:
CA3037738
公开号:
CA3037738A1
申请日:
2017.09.22
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The present disclosure provides anti mucin 16 antibodies : bispecific antibodies (bsAbs) that bind to both MUC16 and CD3 and activate T cells via the CD3 complex in the presence of MUC16-expressing tumors. human IgG antibodies that bind to human andMUC16 (monospecific antibodies).anti-MUC16 antibody drug conjugates which inhibit tumor growth in vivo The antibodies are useful for the treatment of various cancers, including ovarian cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充